Correspondence From BGB – click on the ‘Correspondence Journal’ graphic ABOVE for full details or click on the ‘Ticker Tape’ item below:

Correspondence From BGB – click on the ‘Correspondence Journal’ graphic ABOVE for full details or click on the ‘Ticker Tape’ item below:

Correspondence Includes:
JOURNAL INDEX + SUBJECT TITLE + LINKS TO CONTENTS

**** LATEST ****
12-03-2022

Index No. 220
Subject: Panoramic Study Covid 19 Antiviral treatments

Index No. 212 (Response)
Subject: Validation process for Covid 19 test kits in the private market

Index No. 216 (Response)
Subject: Myocarditis and Pericarditis following Covid 19 vaccination

Index No. 189 (Response 4)
Subject: Primary Care [Moderna Vaccine Covid 19 Immunisation Scheme] Directions 2021

Index No. 209 (Response)
Subject: Commission on Human Medicines – Minutes of meetings: Expert Working Groups

Index No. 218 (Response)
Subject: Fast Track Pathway Tool for NHS Continuing Healthcare

Index No. 219
Subject: Authorisation of special use of SARS-CoV-2 end-point RT-PCR Diagnostic Test System

Index No. 218
Subject: Fast Track Pathway Tool for NHS Continuing Healthcare

Index No. 213 (Response)
Subject: Fast Track Pathway Tool

Index No. 217
Subject: Welsh Government vaccination information leaflet by post

Index No. 122 (Response 2)
Subject: R T – P C R test for Covid 19 diagnosis.

Index No. 94 (Response)
Subject: Covid 19 – Closure of schools and businesses South Ceredigion / North Pembrokeshire – effective from 23 November 2020

Index No. 197 (Response)
Subject: RT-PCR testing at private laboratory suspended

Index No. 182 (Response 2)
Subject: £7.2 million gift of Personal Protective Equipment [P P E] from Wales to Namibia Africa

Index No. 216
Subject: Myocarditis and Pericarditis following Covid 19 vaccination

Index No. 215
Subject: Open letter from “PJH Law” to “National Health Service” dated 3 December 2021

Index No. 214
Subject: New Covid 19 vaccination contract with Pfizer / BioNTech and Moderna

Index No. 213
Subject: Fast Track Pathway Tool

211 Response (BGB Reply To Response)
Subject: Cinema & Co Castle Street Swansea – Closure Order under Public Health [Control of Disease] Act 198411 Response (BGB Reply To Response)

Index No. 211 (Response)
Subject: Cinema & Co Castle Street Swansea – Closure Order under Public Health [Control of Disease] Act 1984

Index No. 212
Subject: Validation process for Covid 19 test kits in the private market

Index No. 211
Subject: Cinema & Co Castle Street Swansea – Closure Order under Public Health [Control of Disease] Act 1984

Index No. 210
Subject: New temporary road layout at Cardigan, Aberaeron, New Quay and Aberystwyth

Index No. 208 (Response)
Subject: Scientific evidence regarding the isolation, purification and sequencing of SARS-CoV-2 virus

Index No. 209
Subject: Commission on Human Medicines – Minutes of meetings: Expert Working Groups

Index No. 200 (Reply To Response)
Subject: Diagnostic test – Covid 19 Delta Variant

Index No. 200 (Response)
Subject: Diagnostic test – Covid 19 Delta Variant

Index No. 208
Subject: Scientific evidence regarding the isolation, purification and sequencing of SARS-CoV-2 virus

Index No. 190 (Response)
Subject: Influenza Vaccines for the 2021 / 22 season

Index No. 178 (Response 2)
Subject: J C V I Annual Register of Members Interests

Index No. 204 (Response)
Subject – Contract Award Notice 2020 / S207-506291 – AI Software package and information system

Index No. 207
Subject: – Tesco Christmas Advertising – Covid 19 Passport

Index No. 122 – Response (From ICO) COMPLAINT BY BGB AGAINST MHRA UPHELD
Subject: R T – P C R test for Covid 19 diagnosis

Index No. 126 (Response)
Subject: Covid 19 national vaccination programme – Accountability for national roll-out decision

Index No. 189 (Response 3)
Subject: Primary Care [Moderna Vaccine Covid 19 Immunisation Scheme] Directions 2021

Idex No. 195 (Response)
Subject: Clarification on role of U K Health Security Agency

Index No.206
Subject: Covid Pill Lagevrio

Index No.135 (Response)
Subject: Serious Adverse Reactions to experimental Covid 19 gene-editing treatments: Financial Compensation Scheme

Index No.205
Subject: Suspension of visitors to all hospitals in H D U H B area

Index No.204
Subject: Contract Award Notice 2020 / S207-506291 – AI Software package and information system

Index No.203
Subject: Covid passes extended to Cinemas, theatres and concert halls from 15 November 2021

Index No.202
Subject: Letter dated 28 October 2021 to Public Accounts Committee House of Commons London

Index No.199 (Response)
Subject: Funding of £200,000 provided by Welsh Government to Swansea University working in conjunction with Innoture

Index No.198 (Response)
Subject: Request for voluntary Regulatory Impact Assessment [R I A]

Index No.192 (Response)
Subject: Protocol for disclosing conflict of interest – Senior medical / scientific advisors to DHSC

Index No. 201
Subject: PAC Report – Test and Trace Update

Index No. 200
Subject: Diagnostic test – Covid 19 Delta Variant.

Index No. 199
Subject: Funding of £200,000 provided by Welsh Government to Swansea University working in conjunction with Innoture

Index No. 189 (Response 2)
Subject: Primary Care [Moderna Vaccine Covid 19 Immunisation Scheme] Directions 2021

Index No. 115 (Response 3)
Subject: Covid 19 – National Vaccine advertising campaign

Index No. 198
Subject: Request for voluntary Regulatory Impact Assessment [R I A]

Index No. 197
Subject: RT-PCR testing at private laboratory suspended

Index No. 191 (Response)
Subject: Project Smart Safety Surveillance [Project 3-S]

Index No. 196
Subject: Covid Status Check Schemes – Wales

Index No. 194 (Response)
Subject: Use of Graphene Oxide in potable water filtration

Index 189 (Response)
Subject: Primary Care [Moderna Vaccine Covid 19 Immunisation Scheme] Directions 2021

Index 180 (Response)
Subject: Coronavirus [Covid 19] – Antibody testing

Index 187 (Response)
Subject: CoV Boost Study – Request for IInformation

Index 119 (Response – 02)
Subject: Coronavirus Crisis – Independent Public Inquiry

Index 117 (Response)
Subject: Covid 19 – Vaccine Passports

Index 116 (Response)
Subject: Covid 19 National Vaccine Advertising Campaign – Stage 1 Complaint

Index 182 (Response)
£7.2 million gift of Personal Protective Equipment [P P E] from Wales to Namibia Africa

Index No. 195
Subject: Clarification on role of U K Health Security Agency

Index No. 194
Subject: Use of Graphene Oxide in potable water filtration

Index No. 177 (Response)
Subject: Use of Graphene Oxide in water filtration

Index No. 193
Subject: Request for voluntary Regulatory Impact Assessment [RIA]

Index No. 188 (Response)
Subject: Covid Passport for events and nightclubs in Wales

Index No. 183 (Response)
Subject: Covid 19 RT-PCR test data presented to J C V I

Index No. 192
Subject: Protocol for disclosing conflict of interest – Senior medical / scientific advisors to DHSC

Index No. 127 (Response)
Subject: Coronavirus Crisis – Conflicts of Interest

Index No. 178 (Response)
Subject: J C V I Annual Register of Members Interests

Index No. 191
Subject: Project Smart Safety Surveillance [Project 3-S]

Index No. 119 (Response)
Subject: Coronavirus Crisis – Independent Public Inquiry

Index No. 190
Subject: Influenza Vaccines for the 2021 / 22 season

Index No. 189
Subject: Primary Care [Moderna Vaccine Covid 19 Immunisation Scheme] Directions 2021

Index No. 188
Subject: Covid Passport for events and nightclubs in Wales

Index No. 187
Subject: CoV Boost Study – Request for Information

Index No. 113 (Response)
Subject: Covid 19 – Mass testing programme for SARS-CoV-2 virus

Index No. 175 (Response)
Subject: Covid 19 Alert Level 0 Wales – FAQ updated 6 August 2021

Index No. 80 (Volume 1) Response 2
Subject: NHS Test and Trace programme – Data sharing with police

Index No. 186
Subject: Covid 19 P C R home test kits

Index No. 185
Subject: Covid Pass for entry to place of work or social event

Index No. 184
Subject: Regulatory Impact Assessment [R I A] for Rating [Wales] [Coronavirus] Regulations 2021

Index No. 183
Subject: Covid 19 RT-PCR test data presented to J C V I

Index No. 182
Subject: £7.2 million gift of Personal Protective Equipment [P P E] from Wales to Namibia Africa

Index No. 181
Subject: PCR Covid 19 Test Providers – harmful practices

Index No. 180
Subject: Coronavirus [Covid 19] – Antibody testing

Index No. 179
Subject: Covid 19 infection data provided to local media & “Gold Command” Status

Index No. 178
Subject: J C V I Annual Register of Members Interests

Index No. 176 (Response)
Subject: Covid 19 risk assessments by hospitality industry in Wales – effective from 7 August 2021.

Index No. 156 (Response)
Subject: Genomic Sequencing data harvested from Covid 19 RT-PCR test results

Index No. 177
Subject: Use of Graphene Oxide in water filtration

Index No. 176
Subject: Covid 19 risk assessments by hospitality industry in Wales – effective from 7 August 2021.

Index No. 166 (Response)
Subject: Health and Social Care Act 2008 – Statutory Instrument [Regulated Activities]

Index No. 173c (Enquiry 03)
Subject: Concerns regarding the reported use of Graphene Oxide in experimental Covid 19 mRNA gene-editing therapies [vaccines]

Index No. 173b (Enquiry 02)
Subject: Concerns regarding the reported use of Graphene Oxide in experimental Covid 19 mRNA gene-editing therapies [vaccines]

Index No. 173 (Response)
Subject: Concerns regarding the reported use of Graphene Oxide in experimental Covid 19 mRNA gene-editing therapies [vaccines]

Index No. 175
Subject: Covid 19 Alert Level 0 Wales – FAQ updated 6 August 2021

Index No. 173b (Enquiry (02)
Subject: Concerns regarding the reported use of Graphene Oxide in experimental Covid 19 mRNA gene-editing therapies [vaccines]

Index No. 136 (Response 02)
Subject: Covid 19 Adverse reactions to experimental gene-editing treatments – Quality of information

Index No. 162 (Response)
Subject: NHS Wales External Whistleblowing Policy

Index No. 174
Subject: Covid 19 Vaccines in Pregnancy [Preg-CoV] Trial- IRAS No. 30115

Index No. 173
Subject: Concerns regarding the reported use of Graphene Oxide in experimental Covid 19 mRNA gene-editing therapies [vaccines]

Index No. 172
Subject: Established Process for obtaining informed consent for vaccinations

Index No. 171
Subject; Pfizer Vaccine roll-out – Vulnerable children aged 12 to 17

Index No. 142 Response (2)
Subject: National Immunisation Management System [N I M S]

Index No. 39 (Vol. 1) Reply To Response
Subject: Harvesting and processing of personal data . . .

Index No. 150 (Response)
Subject: Covid 19 Janssen Vaccine – Marketing Authorisation No. P L G B 00242/0742 – Concerns regarding premature emergency authorisation for use in the human population

Index No. 148 (Response 2)
Subject: Covid 19 vaccination programme – Wales. Request for information. – Spike protein mRNA vaccine.

Index No. 170
Subject: Covid 19 daily testing to avoid the need to self-isolate

Index No. 136 (Response)
Subject: Covid 19 Adverse reactions to experimental gene-editing treatments – Quality of information

Index No. 169
Subject: Invalidity of RT-PCR testing process in Wales

Index No. 168
Subject: Confirmation that Health Secretary has tested positive for Covid 19

Index No. 167
Subject: Covid 19 – Misleading information provided by BBC 16 July 2021

Index No. 166
Subject: Health and Social Care Act 2008 – Statutory Instrument [Regulated Activities]

Index No. 115 (Response – 2)
Subject: Covid 19 – National Vaccine advertising campaign

Index No. 165 (Response)
Subject: V-Safe Covid 19 Vaccine Pregnancy Register

Index No. 165
Subject: V-Safe Covid 19 Vaccine Pregnancy Register

Index No. 164
Subject: Covid 19 gene-editing therapies [vaccines] – Informed Consent

Index No. 163
Subject: Covid 19 – The Science behind the RT-PCR test

Index No. 162
Subject: NHS Wales External Whistleblowing Policy

Index No. 161
Subject: Covid 19 – The Science behind the RT-PCR test

Index No. 160
Subject: BBC New – Coronavirus “Case” Numbers

Index No. 159
Subject: Covid 19 Vaccination roll-out in Wales

Index No. 158
Subject: Covid Safe Zones at Cardigan and Aberaeron

Index No. 153 – BGB Reply To Response
Subject: Covid 19 Ferret Register Wales

Index No. 153 (Response)
Subject: Covid 19 Ferret Register Wales

Index No. 149 (Response)
Subject: Covid 19 Pfizer / BioNTech gene-editing treatment [vaccine] – Emergency authorisation for use in children [12 – 15 years of age.

Index No. 157
Subject: The Influence of the Pharmaceutical Industry

Index No. 156
Subject: Genomic Sequencing data harvested from Covid 19 RT-PCR test results

Index No. 155
Subject: Modifications to public highway and foot-way Pendre Cardigan

Index No. 151 (Response)
Subject: Health Committee Report entitled “The influence of the Pharmaceutical Industry”

Index No. 154 (Response)
Subject: Modifications to public highway layout at Cardigan Town

Index No. 154
Subject: Modifications to public highway layout at Cardigan Town

Index No. 153
Subject: Covid 19 Ferret Register Wales

Index No. 152 (Response)
Subject: COG-UK – Role of Covid 19 RT-PCR test in genome sequencing process

Index No. 152
Subject: COG-UK – Role of Covid 19 RT-PCR test in genome sequencing process

Index No. 151
Subject: Health Committee Report entitled “The influence of the Pharmaceutical Industry”

Index No. 148 (Response)
Subject: Covid 19 vaccination programme – Wales. Request for information. – Spike protein mRNA vaccine.

Index No. 138 (Response)
Subject: Covid 19 Adverse drug reactions to experimental mRNA / DNA based gene-editing treatments

Index No. 143 (Response)
Subject: Tragic death following vaccination

Index No. 115 (Response)
Subject: Covid 19 – National Vaccine advertising campaign

Index No. 150
Subject: Covid 19 Janssen Vaccine – Marketing Authorisation No. P L G B 00242/0742 – Concerns regarding premature emergency authorisation for use in the human population

Index No. 68 (Response 2)
Subject: Covid 19 – Test Trace and Protect Programme [T T P] – Wales

Index No. 145 (Response)
Subject: Covid 19 Johnson & Johnson single dose vaccine

Index No. 142 (Response)
Subject: National Immunisation Management System [N I M S]

Index No. 130 – Response (Additional Information)
Subject: Role of M H R A as independent medical regulator

Index No. 149
Subject: Covid 19 Pfizer / BioNTech gene-editing treatment [vaccine] – Emergency authorisation for use in children [12 – 15 years of age].

Index No. 148
Subject: Covid 19 vaccination programme – Wales. Request for information. – Spike protein mRNA vaccine.

Index No. 139 (Response)
Subject: Cov-Boost Study to evaluate Covid 19 vaccine boosters

Index No. 68 (Response)
Subject: Covid 19 – Test Trace and Protect Programme [T T P] – Wales

Index No. 147
Subject: Covid 19 – Additional £32 Million allocated in Wales for contact tracing based on RT-PCR test results – Request for review

Index No. 146
Subject: Covid 19 Certificate of Vaccination [Vaccine Passport] – Wales

Index No. 145
Subject: Covid 19 Johnson & Johnson single dose vaccine

Index No. 144
Subject: Doctors for Covid Ethics – Paper dated 20 April 2021

Index No. 143
Subject: Tragic death following vaccination

Index No. 134 (Response)
Subject: 60 million Pfizer doses on order for booster vaccines in Autumn 2021

Index No. 142
Subject: National Immunisation Management System [N I M S]

Index No. 141
Subject: Journalistic Integrity at the BBC (Open letter to: Director General and Editor in Chief, BBC Broadcasting House)

Index No. 133 (Response)
Subject: Oxford Covid 19 vaccine study in children [COV 006 Study] – Request for suspension / termination

Index No. 140
Subject: Covid 19 – Sewage monitoring to provide early warning of coronavirus outbreak

Index No. 139
Subject: “Cov-Boost Study” to evaluate Covid 19 vaccine boosters

Index No. 138
Subject: Covid 19 Adverse drug reactions to experimental mRNA / DNA based gene-editing treatments

Index No. 39 (Response 2)
Subject: ICO Case Reference: IC-87082-T9D5

Index No. 131 (Response)
Subject: Covid 19 Moderna vaccine roll-out in Wales

Index No. 137
Subject: Validity of Covid 19 RT-PCR test – external peer review by 22 international virologists, microbiologists and related scientists.

Index No. 136
Subject: Covid 19 Adverse reactions to experimental gene-editing treatments – Quality of information

Index No. 129 (Response)
Subject: Covid 19 Vaccines – Risk v Benefit analysis

Index No. 123 (Response)
Subject: Public Accounts Committee Report – Concerns regarding £37 billion budget for Test and Trace Programme

Index No. 128 (Response)
Subject: Panorama Undercover Investigation – Covid testing laboratory

Index No. 135
Subject: Serious Adverse Reactions to experimental Covid 19 gene-editing treatments: Financial Compensation Scheme

Index No. 134
Subject: 60 million Pfizer doses on order for booster vaccines in Autumn 2021

Index No. 132 Response)
Subject: Synchronisation of data recorded by O N S and H M R

Index No. 133
Subject: Oxford Covid 19 vaccine study in children [COV 006 Study] – Request for suspension / termination

Index No. 112 Response)
Subject: Oxford Covid 19 vaccine study in children [COV 006 Study]

Index No. 130 (Response)
Subject: Role of M H R A as independent medical regulator

Index No. 122 Response)
Subject: R T – P C R test for Covid 19 diagnosis.

Index No. 132
Subject: Synchronisation of data recorded by O N S and H M R

Index No. 131
Subject: Covid 19 Moderna vaccine roll-out in Wales

Index No. 124 (Response)
Subject: General Vaccine Approval Process

Index No. 130
Subject: C J 129: Covid 19 Vaccines – Risk v Benefit analysis

Index No. 129
Subject: Covid 19 Vaccines – Risk v Benefit analysis

Index No. 53 ( 2nd Response)
Subject: Covid 19 – Test Trace and Protect [T T P] Programme – Data Protection Impact Assessmentdex No. 53 (Response)

Index No. 89 (Response)
Subject: Covid 19 – Awarding of private contracts

Index No. 128
Subject: Panorama Undercover Investigation – Covid testing laboratory

Index No. 118 (Response)
Subject: Coronavirus-related contracts – Unlawful Action

Index No. 127
Subject: Coronavirus Crisis – Conflicts of Interest

Index No. 126
Subject: Covid 19 national vaccination programme – Accountability for national roll-out decision

Index No. 125
Subject: Covid 19 vaccines: Adverse Reaction Reports from M H R A

Index No. 109 (Response)
Subject: Covid 19 – SARS-CoV-2: New variant identified at Bristol and Liverpool

Index No. 124
Subject: General Vaccine Approval Process

Index No. 114 (Response)
Subject: Covid 19 Re-calibration of RT-PCR test to detect virus variant VOC202012/02 [South African variant]

Index No. 123
Subject: Public Accounts Committee Report – Concerns regarding £37 billion budget for Test and Trace Programme

Index No. 111 (Response)
Subject: Yellow Card Reporting

Index No. 85 (Response)
Subject: Scientific evidence that the Lateral Flow Test can detect SARS-CoV-2 virus

Index No. 122
Subject: R T – P C R test for Covid 19 diagnosis

Index No. 121 (Response)
Subject: Covid 19 vaccination programme – Adverse Reaction Reports from MHRA

Index No. 110 (Response)
Subject: Covid 19 Vaccination Programme – Post-vaccination deaths

Index No. 121
Subject: Covid 19 vaccination programme – Adverse Reaction Reports from MHRA

Index No. 73 (Response)
Subject: Covid-19 “Case Numbers”

Index No. 120
Subject: Covid 19 RT-PCR Amplification Cycle Threshold [C t] – Economic lockdown Wales

Index No. 119
Subject: Coronavirus Crisis – Independent Public Inquiry

Index No. 118
Subject: Coronavirus-related contracts – Unlawful Action

Index No. 83 (Response)
Subject: Covid 19 Computer modelling design parameters

Index No. 117
Subject: Covid 19 – Vaccine Passports

Index No. 116
Subject: Covid 19 National Vaccine Advertising Campaign – Stage 1 Complaint

Index No. 115
Subject: Covid 19 – National Vaccine advertising campaign

Index No. 114
Subject: Covid 19 Re-calibration of RT-PCR test to detect virus variant VOC202012/02 [South African variant]

Index No. 107 (Response)
Subject: Covid 19 – SARS-CoV-2: New variant from South Africa

Index No. 113
Subject: Covid 19 – Mass testing programme for SARS-CoV-2 virus

Index No. 112
Subject: Oxford Covid 19 vaccine study in children [COV 006 Study]

Index No. 103 (Response)
Subject: C J/103: Pfizer BioNTech Vaccine – Adverse Reaction Reports

Index No. 106 (Response)
Subject: C J 106: Covid 19 Vaccines – Adverse Drug Reaction [A D R]

Index No. 104 (Response)
Subject: Covid 19 – Significant Scientific Evidence of spread within supermarkets

Index No. 111
Subject: Yellow Card Reporting

Index No. 110
Subject: Covid 19 Vaccination Programme – Post-vaccination deaths

Index No. 109
Subject: Covid 19 – SARS-CoV-2: New variant identified at Bristol and Liverpool

Index No. 86 (Response)
Subject: Covid 19 – Face masks

Index No. 108
Subject: Covid 19 Vaccination Programme – Nuremberg Code

Index No. 107
Subject: Covid 19 – SARS-CoV-2: New variant from South Africa

Index No. 70 (Response)
Subject: Senior UK Government Advisors – Conflict of interests

Index No. 106
Subject: C J 106: Covid 19 Vaccines – Adverse Drug Reaction [A D R]

Index No. 105
Subject: Validity of Covid 19 RT-PCR test and Lateral Flow test

Index No. 104
Subject: Covid 19 – Significant Scientific Evidence of spread within supermarkets

Index 87 (Response)
Subject: New Lateral Flow tests for Covid 19 infection

Index No. 103
Subject: C J/103: Pfizer BioNTech Vaccine – Adverse Reaction Reports

Index No. 99 (Response)
Subject: Covid 19 – Pfizer / BioNTech Vaccine

Index No. 80 (Response)
Subject: NHS Test and Trace programme – Data sharing with police

Index No. 96 (Response)
Subject: Covid 19 R T – P C R tests and Lateral Flow tests – False Positive Rate – Pillar 2 community screening

Index No. 97 (Response)
Subject: Covid 19 – New Restrictions [Wales] – effective from 4 December 2020

Index No. 102
Subject: Covid 19 – External Investigation

Index No. 43 (Response)
Subject: Scientific / medical advice to Welsh Government – face masks

Index No. 101 (Response)
Subject: Pfizer / BioNTech vaccine – R.174 Human Medicines Regulations [H M R] 2012

Index No. 90 (Response)
Subject: mRNA Vaccines

Index No. 101
Subject: Pfizer / BioNTech vaccine – R.174 Human Medicines Regulations [H M R] 2012

Index No. 90 (Response)
Medicines and Healthcare Products Regulatory Agency [M H R A]

Index No. 100
Subject: Covid 19 Vaccine – Views of eminent members of the medical and scientific profession.

Index No. 79 (Response)
Subject: Covid 19 – Firebreak Lockdown [Wales] 26 October to 9 November 2020

Index No. 58 (Response)
Subject: Behavioural Insights Team

Index No. 95 (Reply To Response – 01)
Subject: Covid 19 – R T – P C R test

Index No. 95 (Response – 01)
Subject: Covid 19 – R T – P C R test

Index No. 99
Subject: Covid 19 – Pfizer / BioNTech Vaccine

Index No. 59 (Response)
Subject: Covid 19 – Caerphilly Local Lockdown

Index No. 98
Subject: Covid 19 Pfizer / BioNTech Vaccine

Index No. 97
Subject: Covid 19 – New Restrictions [Wales] – effective from 4 December 2020

Index No. 78 (Response – 02)
Subject: Covid 19 Laboratory location – RT-PCR test

Index No. 96
Subject: Covid 19 R T – P C R tests and Lateral Flow tests – False Positive Rate – Pillar 2 community screening

Index No. 95
Subject: Covid 19 – R T – P C R test

Index No. 91 (Response)
Subject: Covid 19 Statistics

Index No. 94
Subject: Covid 19 – Closure of schools and businesses South Ceredigion / North Pembrokeshire – effective from 23 November 2020

Index No. 93
Subject: Impact Assessment – Mandatory wearing of Face Masks

Index No. 50 (Response)
Scientific / medical evidence on use of face covering during Covid-19 crisis

Index No. 64 (Response-02)
Subject: Covid 19 – Rhondda Cynon Taff – Local Lockdown

Index No. 92
Subject: Merthyr Tydfil – Mass Covid 19 testing programme

Index No. 91
Subject: Covid 19 Statistics

Index No. 48 (Response)
Subject: New Covid -19 test announced 3 August 2020

Index No. 90
Subject: mRNA Vaccines

Index No. 89
Subject: Covid 19 – Awarding of private contracts

Index No. 88
Subject: R T – P C R test for Covid 19 diagnosis

Index No. 78 (Response)
Subject: Covid 19 Laboratory location – RT-PCR test

Index No. 45 (Response – 02)
Subject: Covid 19 home test kit

Index No. 87
Subject: New Lateral Flow tests for Covid 19 infection

Index No. 82 (Response)
Subject: BBC News – 29 October 2020 – Death of Mr Bobby Ball

Index No. 86
Subject: Covid 19 – Transparent Face Masks

Index No. 76 (Response)
Subject: CCC – Contact Tracing Service

Index No. 85
Subject: New Lateral Flow Covid 19 diagnostic test

Index No. 84
Subject: National Lockdown England [5 November to 2 December]

Index No. 83
Subject: Covid 19 Computer modelling – Request for information under F O I Act 2000

Index No. 75 (Response)
Subject: Covid-19 Safe Zones – Cardigan Aberaeron, New Quay Aberystwyth

Index No. 82
Subject: BBC News – 29 October 2020 – Death of Mr Bobby Ball

Index No. 81
Subject: Counsel General for Wales [Jeremy Miles] – Public Statement – 28 October 2020

Index No. 64 (Response)
Subject: Covid 19 – Rhondda Cynon Taff – Local Lockdown

Index No. 65 (Response)
Subject: New Covid 19 tests approved for use

Index No. 80
Subject: NHS Test and Trace programme – Data sharing with police

Index No. 54 (Response)
Subject: Aberaeron Town – Modifications to road layout

Index No. 79
Subject: Covid 19 – Firebreak Lockdown [Wales] 26 October to 9 November 2020

Index No. 78
Subject: Covid 19 Laboratory location – RT-PCR test

Index No. 51 (Response)
Subject: Clinical trial – candidate vaccine – LNP-nCoVsaRNA

Index No. 62 (Response)
Subject: Covid 19 – RT-PCR testing process

Index No. 77
Subject: Covid 19 – Case Numbers

Index No. 76
Subject: CCC – Contact Tracing Service

Index No. 61 (Response)
Subject: Covid 19 – Rule of 6 – Legal requirement effective from Monday 14 September in England

Index No. 75
Subject: Covid-19 Safe Zones – Cardigan Aberaeron, New Quay Aberystwyth

Index No. 71 (Response)
Subject: BBC Breakfast Programme – 29 September 2020

Index No. 74
Subject: Publication of Statistics – Hospital Bed Capacity

Index 73
Subject: Covid-19 “Case Numbers”

Index 72
Subject: Royal Glamorgan Hospital – major Covid-19 outbreak

Index No. 71
Subject: BBC Breakfast – 29 September 2020

Index No. 70
Subject: Senior UK Government Advisors – Conflict of interests

Index No. 69
Subject: Covid 19 Lockdown [Cardiff, Swansea and Llanelli] – Request for information

Index No. 68
Subject: Covid 19 – Test Trace and Protect Programme [T T P] – Wales

Index No. 39 (Response)
Subject: Covid 19 – Contact details – Personal data harvesting

Index No. 55 (Response)
Covid 19 – Test Trace and Protect [T T P] Programme – Data Protection Impact Assessment

Index No. 67
F.A.O. Correspondence and Public Enquiries Officer, Public Health England
Subject: Covid 19 and Seasonal Influenza

Index No. 66
F.A.O. First Minister Welsh Government
Subject: Covid 19 and Seasonal Influenza

Index No. 65
Subject: New Covid 19 tests approved for use

Index No. 64
Subject: Covid 19 – Rhondda Cynon Taff – Local Lockdown

Index No. 31 (Response)
Subject: Covid-19 testing and death recording data and statistics

Index No. 51 Response -2)
Subject: Clinical trial – candidate vaccine – LNP-nCoVsaRNA

Index No. 63
Subject: Covid 19 – RT-PCR testing process

Index No. 62
Subject: Covid 19 – RT-PCR testing process

Index No. 61
Subject: Covid 19 – Rule of 6 – Legal requirement effective from Monday 14 September in England

Index 60
Subject: Covid 19 – Request for urgent review

Index 53 (Response)
Subject: Covid 19 – Test Trace and Protect [T T P] Programme – Data Protection Impact Assessment

Index No. 59
Subject: Covid 19 – Caerphilly Local Lockdown

Index No. 56 (Response)
Subject: Covid 19 – Major demonstration Trafalgar Square London – 29 August 2020

Index No. 51 (Response)
Subject: Clinical trial – candidate vaccine – LNP-nCoVsaRNA

Index No. 58
Subject: Behavioural Insights Team

Index No. 57
Subject: Good Morning Britain interview with Piers Corbyn

Index No. 56
Subject: Covid 19 – Major demonstration Trafalgar Square London – 29 August 2020

Index No. 55
Subject: Covid 19 – Test Trace and Protect [T T P] Programme – Data Protection Impact Assessment

Index No. 54
Subject: Aberaeron Town – Modifications to road layout

Index No. 53
Subject: Covid 19 – Test Trace and Protect [T T P] Programme – Data Protection Impact Assessment

Index No. 50 (Response)
Subject: Scientific Advisory Group for Emergencies [SAGE]

Index No. 49 (Response)
Case Reference: IC-48929-W7F4

Index No. 29 (Response)
Subject: Covid 19 Field Hospitals in Wales

Index No. 33 (Second Response)
Subject: Covid-19 [personal data capture and processing]

Index No. 26 (Response)
Subject: Economic “lockdown” imposed by UK Government as a consequence of the Covid-19 crisis

Index No. 52
Subject: Covid-19 testing strategy in Wales

Index No. 25 (Response)
Subject: Covid 19 Antibody Testing Process

Index No. 06 (Response)
Subject: Concerns regarding PCR test and death recording process

Index No. 51
Subject: Clinical trial – candidate vaccine – LNP-nCoVsaRNA

Index No. 50
Subject: Scientific / medical evidence on use of face covering during Covid-19 crisis

Index No. 49
Subject: Harvesting of genetic material [DNA] under Covid-19 test, track and trace programme

Index No. 48
Subject: New Covid -19 test announced 3 August 2020

Index No. 34 (response)
Subject: Covid 19 Track and Trace – Capture and processing of personal data

Index No. 33 (response)
Subject: Covid-19 [personal data capture and processing]

Index No. 21 (Response)
Subject: Product Information Sheet & Safety Data Sheet for RT-PCR test kit

Index No. 47
Subject: Covid-19 – Interpretation of RT-PCR test results

Index No. 46
Subject: Clinical trial – candidate vaccine – LNP-nCoVsaRNA

Index No. 45
Subject: Covid 19 home test kit – consultancy role

Index No. 19B (Response)
Subject: Covid 19 – Safe Zones

Index No. 44 Enquiry
Subject: Covid 19 vaccination trials UK

Index No. 36 (Response) . . .
Subject: Covid 19 vaccination trials UK

Index No 23 (Response)
Subject: Covid 19 – Urban Safe Zones

Index No. 40 (Response)
Subject: P H E Review of Evidence – Covid 19 and Obesity

Index No 43
Subject: Scientific / medical advice to Welsh Government – face masks

Index No. 42
Subject: Covid-19: National statistics relating to death from Covid-19] – Ref: CCC134458

Index No. 17 (Response)
Subject: Scientific / medical evidence for face masks

Index No. 40 Response
Subject: P H E Review of Evidence – Covid 19 and Obesity

Index No 41:
Subject: Covid 19 – New quarantine regulations [26 July 2020]

Index No 40:
Subject: P H E Review of Evidence – Covid 19 and Obesity . . .

Index No 39.
Subject: Harvesting and processing of personal data . . .

Index No 38.
Subject: Government Guidance on Vaccine Damage Payment . . .

Index No 37:
Subject: Investigation into Covid 19 testing process . . .

Index No 36
Subject: Covid 19 vaccination trials UK . . .

Index No 35
Subject: Change of policy relating to face covering . . .

Index No 34
Subject: Harvesting and processing of personal data [2] . . .

Index No 33
Subject: Harvesting and processing of personal data [1] . . .

Index No 32
Subject: Testing and death recording data and statistics [2]. . .

Index No 31
Subject: Testing and death recording data and statistics [1] . . .

Index No 30
Subject: Covid-19 test kits currently used in Wales . . .

Index No 29
Subject: Covid 19 Field Hospitals in Wales . . .

Index No 28
Subject: Complaint to BBC: Case No. CAS-6081489-B7D5D6 . . .

Index No 27
Subject: Lock-down impact assessment requested . . .

Index No 26
Subject: Concerns to Public Health England – economic lockdown . . .

Index No 25
Subject: Covid 19 Antibody Testing Process . . .

Index No 24
Subject: Concerns to UK Statistics Authority . . .

Index No 23
Subject: Covid 19 – Urban Safe Zones . . .

Index No 21 (Response)
Subject: PCR testing process

Index No 22
Subject: Change of policy relating to face covering . . .

Index No 21
Subject: Technical information relating to RT-PCR test kit . . .

Index No 20
Subject: Covid 19 death statistics . . .

Index No 19
Subject: Safe Zones designated by Ceredigion County Council . . .

Index No 18
Subject: Various concerns directed to Public Health Wales . . .

Index No 17
Subject: Information relating to face masks . . .

Index No 16
Subject: Statutes / regulations relating to local lockdown . . .

Index No 15
Subject: Funding to Public Health Wales . . .

Index No 14
Subject: Covid 19 antibody testing . . .

Index No 13
Subject: Funding to “BBC Media Action” . . .

Index No 12
Subject: Harvesting and processing of personal data . . .

Index No 11
Subject: Death recording statistics . . .

Index No 10
Subject: Scrutiny of emergency statutes by parliament . . .

Index No 09
Subject: Complaint to BBC [Index 04 refers] . . .

Index No 08
Subject: Various Covid 19 related concerns . . .

Index No 07
Subject: Covid 19 home testing kit . . .

Index No 06
Subject: PCR test and death recording process . . .

Index No 05
Subject: Complaint to BBC – “BBC Media Action” . . .

Index No 04
Subject: Complaint to BBC – “R” Number . . .

Index No 03
Subject: Scientific evidence for 2 metre social distance rule . . .

Index No 02
Subject: Covid 19 death recording process [2] . . .

Index No 01
Subject: Covid 19 death recording process [1] . . .

© 2024 Big Gee's BLOG

Theme by Anders Norén — Up ↑